Skip to content

Becton, Dickinson and Company BDX Medical Essentials — Revenue

Other segment segments

Interventional
$1.36B+7.4%
Connected Care
$1.12B
BioPharma Systems
$590M

Similar metrics at other companies

Aveanna Healthcare Holdings Inc. logo
AVAHMedical Solutions — Revenue
$45.65M+7.4%
Varex Imaging Corporation logo
VREXMedical — Revenues, net
$156.2M+1.6%
Novanta logo
NOVTMedical Solutions — Revenue
$126.46M+14.8%
Gentherm logo
THRMMedical — Revenue
$11.54M-3.7%
Mirion Technologies logo
MIRMedical Segment — Total revenues
$72.1M+5.1%
Allient Inc. logo
ALNTMedical — Revenue
$19.47M+1.9%

Other financials

Income statement

See full
Revenue$4.7B+5.2%
Gross profit$2.2B+15.7%
Operating income$93.0M-75.7%
Net income-$311.0M-201%
EPS (diluted)-$1.11-204%

Balance sheet

See full
Cash & equivalents$1.0B+49.0%
Total debt$14.7B-16.8%
Total equity$24.1B-4.4%
Total assets$50.8B-6.7%

Cash flow

See full
Operating cash flow$671.0M
CapEx$125.0M+9.6%
Free cash flow$546.0M

Valuation

See full
Market cap$42.96B-12.6%
Enterprise value$56.65B-14.0%
P/E37.8×+6.7×
P/S-0.4×

Profitability

See full
Gross margin46.8%+2.5pp
Operating margin10.4%+0.1pp
Net margin5.3%-2.1pp
FCF margin16.4%

Returns & leverage

See full
Return on equity4.6%-1.3pp
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Becton, Dickinson and Company's medical essentials — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Becton, Dickinson and Company's medical essentials — revenue?
Becton, Dickinson and Company (BDX) reported medical essentials — revenue of $1.65B in Q1 2026.
What does medical essentials — revenue mean?
This metric represents the total net sales generated by the Medical Essentials business segment, which focuses on high-volume, foundational medical products like needles, syringes, and sharps-disposal units. It serves as a primary indicator of the segment's market demand and revenue-generating capacity within the broader medical technology portfolio.